Literature DB >> 19463216

Eosinophilic esophagitis: pathophysiology and optimal management.

Carol Garrean1, Ikuo Hirano.   

Abstract

Eosinophilic esophagitis (EoE) is an increasingly recognized disease characterized by esophageal symptoms accompanied by increased esophageal mucosal eosinophilia. The reasons for the increasing prevalence and understanding of the pathogenesis of EoE are areas of active investigation. Food and environmental allergy, host immunologic predisposition, and interactions with gastroesophageal reflux disease have emerged as important aspects of the disease. The optimal management of EoE is controversial and evolving. Therapeutic options include medical therapy with acid suppression, corticosteroids, and biologic agents. Elimination diets and endoscopic esophageal dilation have shown effectiveness. Management strategies for individual patients range from clinical observation to multimodal therapy, depending on the clinical presentation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463216     DOI: 10.1007/s11894-009-0028-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  37 in total

1.  Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction.

Authors:  Allison D Fryer; Louis H Stein; Zhenying Nie; Damian E Curtis; Christopher M Evans; Simon T Hodgson; Peter J Jose; Kristen E Belmonte; Erin Fitch; David B Jacoby
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

Review 2.  Gastrointestinal eosinophils.

Authors:  M E Rothenberg; A Mishra; E B Brandt; S P Hogan
Journal:  Immunol Rev       Date:  2001-02       Impact factor: 12.988

3.  Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

Authors:  Amindra S Arora; Jean Perrault; Thomas C Smyrk
Journal:  Mayo Clin Proc       Date:  2003-07       Impact factor: 7.616

4.  Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.

Authors:  Elizabeth T Schaefer; Joseph F Fitzgerald; Jean P Molleston; Joseph M Croffie; Marian D Pfefferkorn; Mark R Corkins; Joel D Lim; Steven J Steiner; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

Review 5.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

Review 6.  Eosinophilic esophagitis: asthma of the esophagus?

Authors:  Amindra S Arora; Kiyoshi Yamazaki
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

7.  Histopathologic variability in children with eosinophilic esophagitis.

Authors:  Ameesh Shah; Amir F Kagalwalla; Nirmala Gonsalves; Hector Melin-Aldana; B U K Li; Ikuo Hirano
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

Review 8.  Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review.

Authors:  Evan S Dellon; Ademola Aderoju; John T Woosley; Robert S Sandler; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2007-07-07       Impact factor: 10.864

9.  Eosinophilic oesophagitis: a novel treatment using Montelukast.

Authors:  S E A Attwood; C J Lewis; C S Bronder; C D Morris; G R Armstrong; J Whittam
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids.

Authors:  A M Schoepfer; J Gschossmann; U Scheurer; F Seibold; A Straumann
Journal:  Endoscopy       Date:  2008-02       Impact factor: 10.093

View more
  7 in total

1.  Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

Review 2.  Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody.

Authors:  Deborah A Smith; Elisabeth A Minthorn; Misba Beerahee
Journal:  Clin Pharmacokinet       Date:  2011-04       Impact factor: 6.447

Review 3.  Advances in diagnostic testing for gastroesophageal reflux disease.

Authors:  Andrew J Gawron; Ikuo Hirano
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.

Authors:  Jessica Rajan; Robert O Newbury; Arjun Anilkumar; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2015-07-30       Impact factor: 10.793

Review 5.  Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters.

Authors:  Matthew A Rank; Rajiv N Sharaf; Glenn T Furuta; Seema S Aceves; Matthew Greenhawt; Jonathan M Spergel; Yngve T Falck-Ytter; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2020-05       Impact factor: 6.347

6.  Eosinophilic esophagitis.

Authors:  Stuart Carr; Wade Watson
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-10       Impact factor: 3.406

7.  Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.

Authors:  Matthew A Rank; Rajiv N Sharaf; Glenn T Furuta; Seema S Aceves; Matthew Greenhawt; Jonathan M Spergel; Yngve T Falck-Ytter; Evan S Dellon
Journal:  Gastroenterology       Date:  2020-05       Impact factor: 33.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.